Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2160 - BLAZE (Boosted Lesion Ablative Zone Escalation) in Spinal Radiation Therapy: A Systematic Review and Meta-Analysis of Safety and Efficacy
Speaker: Narvaez Rojas, Alexis, MD - Maimonides Medical Center, New York, NY
3:00 PM - 4:00 PM ET

2161 - Utility of Early Postoperative Radiotherapy for WHO Grade 2 Meningiomas
Speaker: Natarajan, Jyotsna, MD, BS - UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
3:00 PM - 4:00 PM ET

2162 - Revealing Sex-Specific Treatment Outcomes and Molecular Signatures in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy: Implications for Personalized Therapy
Speaker: Navarria, Federico, MD - Department of Radiation Oncology, Centro di Riferimento Oncologico, Aviano
3:00 PM - 4:00 PM ET

2163 - Stereotactic Body Radiation Therapy Combined with Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Comprehensive Meta-Analysis
Speaker: Newman, Neil, MD, MS - Home, San Antonio , TX
3:00 PM - 4:00 PM ET

2164 - 18F-Faza PET Radiomics for Prediction of Temporal Lobe Radiation Necrosis after Proton Therapy In Skull Base Chordoma
Speaker: Nicaise, Benjamin, MD - Institut Curie, Paris
3:00 PM - 4:00 PM ET

2165 - Clinical Course and Dose-Volume Analysis of Radiation-Induced Hypothyroidism after IMRT for Cervical Esophageal Cancer
Speaker: Nishibuchi, Ikuno, MD, PhD - Department of Radiation Oncology, Hiroshima University, Hiroshima, Hiroshima
3:00 PM - 4:00 PM ET

2166 - Comparative Survival Outcomes Between Surgery and Definitive Chemoradiotherapy Following Induction Immunochemotherapy in Patients with Resectable Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis of a Multicenter Study In China
Speaker: Pang, Qingsong, MD, PhD - Tianjin Cancer Hospital, Tianjin, Tianjin
3:00 PM - 4:00 PM ET

2167 - Radiation Necrosis after Pencil Beam Scanning Proton Therapy for CNS Tumors: Incidence and Timing
Speaker: Panse, Drishti, MD, BS - Icahn School of Medicine at Mount Sinai, New York, NY
3:00 PM - 4:00 PM ET

2168 - Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy for Brain Metastases Improving Local Control and Reducing Cranial Toxicity
Speaker: Pari Mitre, Lucas, MD - UT Southwestern, Dallas, TX
3:00 PM - 4:00 PM ET

2169 - Redefining the Limits of SRS for Brain Metastases: A Large Contemporary Cohort Analysis
Speaker: Parker, Mitchell, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:00 PM - 4:00 PM ET

2170 - Predictors of Leptomeningeal Disease after Postoperative Stereotactic Radiosurgery for Resected Brain Metastases: A Multi-Institutional Experience
Speaker: Patel, Mira, MD, BS - UChicago Medicine, Chicago, IL
3:00 PM - 4:00 PM ET

2171 - Impact of Tumor Length on Locoregional Control following Radical Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Speaker: Patoriya, Radhika, MD - Kiran Multi Super Speciality Hospital, Surat, Surat, Gujarat